What is Ceritinib 150 mg?
Ceritinib 150 mg is a prescription medication used primarily in the treatment of non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as ALK inhibitors. Developed and manufactured by Novartis India Ltd, this medication specifically targets cancer cells that express anaplastic lymphoma kinase (ALK) gene rearrangements.
This oral medication offers an advanced option for patients diagnosed with ALK-positive NSCLC, providing targeted therapy aimed at stopping tumor progression. Ceritinib is designed for adults whose cancer has either progressed despite previous treatment or who cannot tolerate other ALK inhibitors.
Approved for use in various countries including Malaysia, Ceritinib 150 mg provides a therapeutic approach with a focus on improving patient quality of life and managing disease symptoms effectively. It is widely prescribed by oncology specialists for eligible patients after a thorough diagnostic assessment.
Uses of Ceritinib 150 mg
- Treatment of ALK-positive non-small cell lung cancer
- Management of metastatic NSCLC in patients resistant to other ALK inhibitors
- Targeted therapy for tumors expressing ALK gene rearrangements
- Used as an alternative for patients intolerant to crizotinib
How Ceritinib 150 mg Works
Ceritinib 150 mg works by selectively inhibiting the activity of the anaplastic lymphoma kinase (ALK) enzyme. ALK gene fusions or rearrangements cause the production of abnormal proteins that promote cancer cell growth and survival. By blocking these proteins, Ceritinib impairs the ability of cancer cells to multiply and spread.
This targeted mechanism helps to slow progression or shrink tumors in patients whose cancers are driven by ALK gene alterations. Because Ceritinib specifically attacks these abnormal proteins, it offers a more focused treatment with potentially fewer effects on normal cells than traditional chemotherapy.
How to take Ceritinib 150 mg
Take Ceritinib exactly as prescribed by your healthcare provider. It is typically administered orally once daily on an empty stomach, generally at least 1 hour before or 2 hours after eating.
Swallow the capsule whole with water. Do not crush, chew, or open the capsule. Consistency in taking the medication daily at the same time is essential for optimal effectiveness. Follow the treatment schedule recommended and do not alter dosage without consulting your doctor.
Benefits of Ceritinib 150 mg
- Targeted treatment leading to better tumor control
- Effective for ALK-positive NSCLC patients resistant to other therapies
- Oral administration allows convenient at-home use
- Potential to improve progression-free survival times
- May reduce the severity of cancer-related symptoms
Dosage and Administration
The typical dose of Ceritinib is 150 mg once daily taken orally. Dose adjustments may be necessary based on patient tolerance and side effects. It is important to undergo regular medical evaluations during treatment to monitor response and any adverse effects.
Do not change or stop taking Ceritinib without medical advice. Your doctor may adjust your dose or treatment schedule depending on your individual condition and therapy response.
Who Should Use Ceritinib 150 mg?
Ceritinib 150 mg is indicated for adult patients diagnosed with ALK-positive non-small cell lung cancer. It is especially suitable for those who have experienced progression on or cannot tolerate other ALK-targeted therapies such as crizotinib.
Patients must undergo genetic testing to confirm ALK gene rearrangements before starting treatment. It is typically prescribed by oncologists familiar with targeted lung cancer treatments.
Who Should Avoid Ceritinib 150 mg?
Ceritinib should be avoided by individuals who have known hypersensitivity to Ceritinib or any ingredient in the formulation. It is not recommended for use during pregnancy or breastfeeding due to potential risks to the fetus or baby.
Patients with significant liver or heart issues should inform their healthcare provider before starting this medication. Use caution and medical supervision is necessary in these cases.
Side Effects of Ceritinib 150 mg
- Nausea
- Vomiting
- Diarrhea
- Fatigue
- Liver enzyme elevations
- Abdominal pain
- Loss of appetite
- Shortness of breath
- Edema (swelling)
- Increased blood sugar levels
- Constipation
- Rash
Safety Advice
- Inform your doctor about all existing medical conditions
- Do not consume grapefruit or grapefruit juice while on Ceritinib
- Regular liver function tests are recommended
- Report any unusual symptoms such as severe abdominal pain or breathing difficulties immediately
- Use effective contraception during treatment and for some time after stopping the medication
- Avoid missing doses to maintain treatment efficacy
Drug Interactions
- Strong CYP3A inhibitors (e.g., ketoconazole) may increase Ceritinib levels
- Strong CYP3A inducers (e.g., rifampin) may reduce Ceritinib effectiveness
- Certain antihistamines and antifungals may interact with Ceritinib
- Avoid co-administration with medications that prolong QT interval
Storage Instructions
Store Ceritinib capsules at room temperature between 20°C to 25°C (68°F to 77°F). Protect from moisture and light. Keep the medication out of reach of children. Do not use past the expiration date printed on the packaging.
Where to buy Ceritinib 150 mg in Malaysia?
Ceritinib 150 mg can be purchased at licensed pharmacies and specialized oncology clinics across Malaysia. It is important to buy from reputable sources to ensure product authenticity and safety.
Many healthcare providers and hospitals collaborate with certified distributors of Novartis India Ltd products. Online pharmaceutical platforms with verified credentials may also offer Ceritinib but verify legitimacy before purchasing.
Frequently Asked Questions (FAQ)
What is the price of Ceritinib 150 mg in Malaysia?
The price of Ceritinib 150 mg can vary depending on the pharmacy and availability. It is advisable to check with local authorized sellers or your healthcare provider for the most accurate and current pricing.
What happens if I miss a dose?
If you miss a dose of Ceritinib, take it as soon as you remember unless it is close to the time for your next dose. Do not double the dose to catch up. Contact your doctor for guidance if you are unsure.
Where can I find Ceritinib 150 mg for sale?
Ceritinib 150 mg is available at licensed pharmacies, oncology centers, and certified online pharmaceutical retailers in Malaysia. Ensure the source is trustworthy to avoid counterfeit products.
Is Ceritinib 150 mg available in Malaysia?
Yes, Ceritinib 150 mg is registered and available for use in Malaysia, prescribed mainly for patients with ALK-positive non-small cell lung cancer under medical supervision.
Can Ceritinib 150 mg be taken with food?
Ceritinib should be taken on an empty stomach, at least 1 hour before or 2 hours after meals, to ensure optimal absorption and effectiveness.
Are there any special precautions during Ceritinib treatment?
Regular monitoring of liver function, heart health, and blood sugar levels is essential during treatment. Always follow medical advice and report any severe side effects.
How long does it take for Ceritinib to show effects?
Response times vary; some patients may see improvements within weeks, while others require longer. Continuous medical follow-up is important to assess treatment effectiveness.
Conclusion
Ceritinib 150 mg represents a significant advancement in the targeted treatment of ALK-positive non-small cell lung cancer. Manufactured by Novartis India Ltd, it offers patients a targeted therapy option that can slow disease progression and help manage symptoms. Proper administration, consistent dosing, and medical supervision are crucial for achieving the best outcomes. For patients in Malaysia, this medication is accessible through authorized healthcare channels, ensuring both safety and quality in cancer care.
Leave A Review